Last reviewed · How we verify
Tiotropium 5 µg q.d. (tiotropium-5-g-q-d)
Tiotropium 5 µg q.d. acts as a long-acting muscarinic antagonist, blocking M3 receptors in the airways to reduce bronchoconstriction.
At a glance
| Generic name | tiotropium-5-g-q-d |
|---|---|
| Sponsor | Pfizer Inc. |
| Phase | Phase 2 |
Mechanism of action
Tiotropium 5 µg q.d. works by blocking M3 muscarinic receptors in the lungs, which helps to relax the muscles around the airways and improve breathing. This action reduces symptoms of chronic obstructive pulmonary disease (COPD).
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tiotropium 5 µg q.d. CI brief — competitive landscape report
- Tiotropium 5 µg q.d. updates RSS · CI watch RSS
- Pfizer Inc. portfolio CI